In the context of brain diseases, recent studies implicate excess HDAC function in Alzheimer’s disease (AD) and suggest decreasing HDAC function with drugs like SAHA could potentially improve cognitive functions [11]. Here, HDAC9 is linked to early-onset autosomal dominant Alzheimer disease.